Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WDR7 overlapping transcript 1 (WDR7-OT1) is a long non-coding RNA gene located on chromosome 18q21.31 (hg38: chr18:57,027,832-57,038,845, forward strand). It is classified as an "overlapping transcript" because its genomic region overlaps the protein-coding gene WDR7 on the same strand. Like other lncRNAs, WDR7-OT1 is presumed to act by regulating chromatin state, gene expression, or molecular interactions at the RNA or DNA level, although there is currently no specific published data describing its biological function, disease association, or therapeutic relevance. No direct links to drugs, mechanisms of action, or biomarker use are described in available resources. If further research provides functional or therapeutic relevance, these entries should be updated accordingly. For now, WDR7-OT1 is best characterized as a long non-coding RNA of unestablished clinical or pharmacological significance.
Not applicable (no drugs targeting this RNA are currently reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WDR7 overlapping transcript 1 (WDR7-OT1).